1276:HKG
Jiangsu Hengrui Pharmaceuticals Co Ltd
HK$60.20
arrow_upward
+3.44%(+2.00) 1D
May 29, 4:08:24 PM GMT+8 · HKD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 1276...
Open
HK$58.95
High
HK$60.50
Low
HK$57.25
Mkt. cap
366.04B
Avg. vol.
3.65M
Volume
6.37M
Dividend
0.38%
Quarterly dividend
HK$0.06
Ex-dividend date
May 27, 2026
P/E ratio
44.87
52-wk high
HK$95.20
52-wk low
HK$53.55
EPS
HK$1.34
No. of employees
21K
Open
HK$58.95
High
HK$60.50
Low
HK$57.25
Mkt. cap
366.04B
Avg. vol.
3.65M
Volume
6.37M
Dividend
0.38%
Quarterly dividend
HK$0.06
Ex-dividend date
May 27, 2026
P/E ratio
44.87
52-wk high
HK$95.20
52-wk low
HK$53.55
EPS
HK$1.34
No. of employees
21K
News stories
From sources across the web
marketscreener.com
·
12 hours ago
Hengrui Pharma Secures China Registration for Gout Drug; Shares Up 3%
Profile
Jiangsu Hengrui Pharmaceuticals Company Ltd., also known as Jiangsu Hengrui, is a Chinese pharmaceutical company that manufactures and distributes various types of drug packaging materials, cancer-treating antineoplastics, cardiovascular medication, painkillers, antibiotics, and related products. It is the largest listed pharmaceutical company in China. Wikipedia
About Jiangsu Hengrui Pharmaceuticals Co Ltd
AI content may include mistakes. Learn more